You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pomalidomide-dexamethasone

Showing 26 - 50 of 2,305
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma, Multiple Myeloma in Relapse, Tumors Trial (Belantamab Mafodotin-Blmf, Daratumumab, Pomalidomide)

Not yet recruiting
  • Multiple Myeloma
  • +8 more
  • Belantamab Mafodotin-Blmf
  • +3 more
  • (no location specified)
Oct 13, 2022

Multiple Myeloma Trial (pomalidomide, Bortezomib, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jun 20, 2022

Relapsed or Refractory Multiple Myeloma Trial (Daratumumab, Pomalidomide)

Withdrawn
  • Relapsed or Refractory Multiple Myeloma
  • (no location specified)
Jan 26, 2023

Refractory Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma Trial in United States (ixazomib citrate, dexamethasone,

Active, not recruiting
Has Results
  • Refractory Plasma Cell Myeloma
  • Recurrent Plasma Cell Myeloma
  • ixazomib citrate
  • +2 more
  • Scottsdale, Arizona
  • +4 more
Mar 28, 2022

Relapsed/Refractory Multiple Myeloma Trial in La Jolla (Ixazomib, Pomalidomide, Dexamethasone)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • La Jolla, California
    UCSD Moores Cancer Center
Mar 7, 2022

Multiple Myeloma Trial (Pembrolizumab, Pomalidomide, Dexamethasone)

Terminated
Has Results
  • Multiple Myeloma
  • Pembrolizumab
  • +2 more
  • (no location specified)
Sep 13, 2021

AL Amyloidosis Trial in France (Isatuximab)

Recruiting
  • AL Amyloidosis
  • Amiens, France
  • +14 more
Aug 9, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Duarte (Dexamethasone, Leflunomide, Pomalidomide)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Duarte, California
    City of Hope Medical Center
Jan 10, 2022

Multiple Myeloma Trial in Torino (Carfilzomib, Pomalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Torino, Italy
    Dipartimento di Biotecnologie Molecolari e Scienze per la Salute
Mar 24, 2022

Multiple Myeloma in Relapse Trial in Aurora (Selinexor, Pomalidomide, Daratumumab)

Recruiting
  • Multiple Myeloma in Relapse
  • Aurora, Colorado
    University of Colorado Hospital
Jan 31, 2023

Multiple Myeloma Trial in Milwaukee (Isatuximab (for run-in portion), Isatuximab (for expansion), Pomalidomide)

Recruiting
  • Multiple Myeloma
  • Isatuximab (for run-in portion)
  • +4 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Feb 18, 2022

Plasma Cell Myeloma Trial in Atlanta (Carfilzomib, Dexamethasone, Pomalidomide)

Recruiting
  • Plasma Cell Myeloma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Oct 5, 2021

Multiple Myeloma Trial in Shanghai (Selinexor, Thalidomide, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Mar 3, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Carfilzomib, Dexamethasone, Pomalidomide)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 3, 2022

Multiple Myeloma Trial in Beijing (Drug: Ixazomib Drug:pomalidomide Drug:dexamethasone)

Recruiting
  • Multiple Myeloma
  • Drug: Ixazomib Drug:pomalidomide Drug:dexamethasone
  • Beijing, Beijing, China
    PekingUMCH
Aug 15, 2021

Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Phoenix, Jacksonville, Rochester

Recruiting
  • Plasma Cell Myeloma
  • +3 more
  • Bone Marrow Biopsy
  • +3 more
  • Phoenix, Arizona
  • +2 more
Jan 18, 2023

Multiple Myeloma, Renal Impairment, Tumors, Plasma Cell Trial in Greece (Isatuximab, Pomalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • +7 more
  • Athens, Greece
  • +5 more
Mar 17, 2022

Multiple Myeloma Trial in Atlanta, Boston (ACE-011, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Atlanta, Georgia
  • +3 more
Oct 28, 2021

Multiple Myeloma-Light Chain Only, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (drug,

Terminated
Has Results
  • Multiple Myeloma-Light Chain Only
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2021

Multiple Myeloma Trial in Worldwide (ACY-241, Pomalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +24 more
Dec 15, 2022

Recurrent Plasma Cell Myeloma Trial in United States (Daratumumab, Dexamethasone, Pomalidomide)

Withdrawn
  • Recurrent Plasma Cell Myeloma
  • Daratumumab
  • +2 more
  • Wichita, Kansas
  • +4 more
Jun 13, 2022

Multiple Myeloma Trial in Torino (Pomalidomide, Cyclophosphamide, Dexamethasone)

Terminated
Has Results
  • Multiple Myeloma
  • Torino, Italy
    Fondazione EMN Italy Onlus
Feb 16, 2021

Relapsed and/or Refractory Multiple Myeloma Trial in Canada (GSK2857916 with Pomalidomide and Dexamethasone)

Recruiting
  • Relapsed and/or Refractory Multiple Myeloma
  • GSK2857916 with Pomalidomide and Dexamethasone
  • Edmonton, Alberta, Canada
  • +8 more
Feb 14, 2022

Multiple Myeloma, Deletion 17P Syndrome Trial in Italy (Daratumumab, Pomalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Deletion 17P Syndrome
  • Ancona, Italy
  • +14 more
Mar 24, 2022

Multiple Myeloma Trial in United States (Elotuzumab, Pomalidomide, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Boston, Massachusetts
  • +5 more
Oct 28, 2021